Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO Centers in Haiti.
Federal appeals court restricts access to abortion pill, attempting to revert back to FDA’s 2016 restrictions on the drug
The abortion drug mifepristone is once again facing court-imposed restrictions as a federal Fifth Circuit Court of Appeals ruled Wednesday that until final judgment, the
August 17, 2023